FEB 12, 2016 6:45 AM PST

A Blood Test to Reveal IQ Levels and Predict Alzheimer's Risk

WRITTEN BY: Xuan Pham
Blood-borne biomarker protein could revolutionize diagnosis of Alzheimer's

It seems that scientists are on the verge of revolutionizing how doctors diagnose and treat early stage Alzheimer’s. Earlier this year, a group of researchers reported a detectable urine odor biomarker in a mouse model of the disease. Now, researchers from Tel Aviv University and Harvard University have found a correlation between a blood-borne biomarker protein and declining cognitive conditions. The discovery could propel a new diagnostic blood test to detect the early signs of Alzheimer’s disease.
 
Currently, diagnosis of Alzheimer’s disease is very limited and time-consuming. Doctors and experts have to conduct a battery of cognitive tests to look for impairments in cognition, memory, social functioning, and behaviors. The tests are highly subjective, but remain the best practice for diagnosing Alzheimer’s, as the true confirmation can only come from brain autopsy reports.
 
 
But researchers now propose that a blood-based protein could be the new biomarker for detecting Alzheimer’s.
 
The protein is known as activity-dependent neuroprotective protein (ADNP), and is essential for brain formation. Mutations in this gene are frequently associated with autism spectrum disorder. Moreover, ADNP is the only protein that has been shown to decrease significantly in the serum of Alzheimer’s patients.
 
In the current study, researchers from Tel Aviv University and Harvard University sought to uncover a pattern of ADNP levels in 11 healthy elderly individuals, 15 mild cognitively impaired (MCI) patients, and 17 Alzheimer’s dementia patients. They found that higher ADNP protein levels in the blood serum are significantly associated with higher “premorbid intelligence,” which is defined as a person’s cognitive function prior to the onset of brain disease. Conversely, lower ADNP mRNA levels are associated with higher amyloid presence in cognitively normal elderly individuals.
 
To put it another way, “The more ADNP RNA found in the blood cells, the fewer aggregates found in the brain of elderly cognitively normal individuals,” said Illana Gozes, study leader and professor at the Tel Aviv University in Israel. “We have found a clear connection between ADNP levels in the blood and amyloid plaques — a hallmark Alzheimer’s — in the brain.”
 
They also reported that ADNP levels correlate with intelligence quotient (IQ) levels. Gozes says, “…the more ADNP in the serum, the higher the person’s IQ level.”
 
The consequences of these findings could potentially improve how doctors assess intelligence decline in pre-Alzheimer’s and Alzheimer’s patients. The authors propose that instead of the laborious subjective cognitive tests that are currently in practice, doctors could use regular blood tests to measure ADNP levels, which can disclose Alzheimer’s risks and related IQ status.
 
“This study has provided the basis to detect this biomarker in routine, non-invasive blood tests, and it is known that early intervention is invaluable to Alzheimer’s patients,” said Prof. Gozes. “We are now planning to take these preliminary findings forward into clinical trials — to create a pre-Alzheimer’s test that will help to tailor potential preventative treatments.”

Additional source: EurekAlert!
 
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 24, 2020
Clinical & Molecular DX
New Portable MRI Swoops Into Hospital Rooms, Gets FDA Nod
AUG 24, 2020
New Portable MRI Swoops Into Hospital Rooms, Gets FDA Nod
Magnetic resonance imaging, or MRI, is a medical imaging technique that uses powerful magnetic fields and radio waves to ...
AUG 27, 2020
Clinical & Molecular DX
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
AUG 27, 2020
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
  Many diseases such as breast cancer have both a strong genetic component, coupled with a variety of environmental ...
SEP 07, 2020
Cell & Molecular Biology
With Nanopores, Small Samples Detect Diseases
SEP 07, 2020
With Nanopores, Small Samples Detect Diseases
If you've ever been through a battery of tests while doctors try to find a diagnosis for an ailment, you know that many ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
OCT 06, 2020
Clinical & Molecular DX
A Smart Tattoo That Could Save Your Life
OCT 06, 2020
A Smart Tattoo That Could Save Your Life
Color-changing tattoos, powered by nanotechnology, that sense imbalances in your biochemistry providing a visual signal ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
Loading Comments...